Skip to content

Clinical trials

Observational Lung Neoplasms trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Observational Country / region: Czechia Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20161
20181
20201
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Bristol-Myers Squibb1
Carebot s.r.o.1
Ceska Lekarska Spolecnost Jana Evangelisty Purkyne z.s.1
Charles University, Czech Republic1
Sandoz1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms6
Ovarian Neoplasms2
Urinary Bladder Neoplasms2
Biliary Tract Neoplasms1
Breast Neoplasms1
Carcinoma, Bronchogenic1
Cardiomegaly1
Colorectal Neoplasms1
Disease1
Endometrial Neoplasms1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.